1-4 of 4
Sarah T. Wilkinson
Close
Sort by
Journal Articles

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

Sarah T. Wilkinson, Kristie A. Vanpatten, Diane R. Fernandez, Patrick Brunhoeber, Karl E. Garsha, Betty J. Glinsmann-Gibson, Thomas M. Grogan, Julie Teruya-Feldstein, Lisa M. Rimsza
Journal: Blood
Blood (2012) 119 (6): 1459–1467.
https://doi.org/10.1182/blood-2011-07-363820
Published: 2012
Journal Articles

Lack of Major Histocompatibility Class II (MHCII) Protein and Decreased Immunosurveillance in Plasmablastic Lymphoma (PBL)

Monika Schmelz, PhD, Santiago Montes-Moreno, MD, Miguel Piris, MD, Sarah T Wilkinson, PhD, Lisa M. Rimsza, MD
Journal: Blood
Blood (2011) 118 (21): 5186.
https://doi.org/10.1182/blood.V118.21.5186.5186
Published: 2011
Journal Articles

A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.

Sarah T. Wilkinson, PhD, Roshanak Bob, MD, Harald Stein, MD, Mark Schwartz, PhD, Rita M. Braziel, MD, Randy D. Gascoyne, MD, Lisa M. Rimsza, MD
Journal: Blood
Blood (2009) 114 (22): 1941.
https://doi.org/10.1182/blood.V114.22.1941.1941
Published: 2009
Journal Articles

Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV.

Sarah T Wilkinson, PhD, Diane R Fernandez, MD, Shawn P Murphy, PhD, Wing C. Chan, MD, Randy D. Gascoyne, MD, Elias Campo, MD, Elaine S. Jaffe, MD, Louis M. Staudt, MD, PhD, Jan Delabie, MD, PhD, Andreas Rosenwald, MD, Lisa M Rimsza, MD
Journal: Blood
Blood (2008) 112 (11): 1786.
https://doi.org/10.1182/blood.V112.11.1786.1786
Published: 2008